The Etiology of New-onset Status Epilepticus

December 13, 2022 updated by: Jie Liu

Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital

This study will help to identify the causes of new epilepsy and provide a basis for the development of a rational and standardized diagnosis and treatment plan to reduce the rate of disability and death.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Sichuan
      • Chengdu, Sichuan, China
        • Jie Liu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients were selected strictly according to the inclusion and exclusion criteria from January 2021 to December 2022 at Sichuan Academy of Medical Sciences. Inpatient NOSE patients at Sichuan Provincial People's Hospital

Description

Inclusion Criteria:

  • Clinical diagnosis of Status Epilepticus
  • Sign the informed consent form

Exclusion Criteria:

  • Patients with previous epilepsy
  • Missing information such as basic information and treatment history
  • Long-term smoking, alcohol and drug abuse
  • Pregnant and breastfeeding women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
status epilepticus with autoimmune encephalitis; status epilepticus without autoimmune encephalitis
To study the relationship between autoimmune-related antibody titres and prognosis during the six-month follow-up
Diagnostic test: Perform autoimmune encephalitis titer tests
We only follow up without intervention.
Other Names:
  • We only follow up without intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Death
Time Frame: 2021-12--2022-12
2021-12--2022-12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Jie Liu

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

August 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

December 4, 2022

First Submitted That Met QC Criteria

December 4, 2022

First Posted (Actual)

December 12, 2022

Study Record Updates

Last Update Posted (Estimate)

December 15, 2022

Last Update Submitted That Met QC Criteria

December 13, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Liujiessy

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Status Epilepticus

Clinical Trials on Perform autoimmune encephalitis titer tests

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe